Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States

PURPOSE: Patients with bone metastases are at an increased risk of experiencing morbidity due to bone complications, and bone-targeting agents (BTA) are indicated for the prevention of these complications. Population-based estimates of the prevalence of bone metastases associated with solid tumors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Rohini K, Adhia, Avanti, Wade, Sally W, O’Connor, Emily, Arellano, Jorge, Francis, Kevin, Alvrtsyan, Hasmik, Million, Ryan P, Liede, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514316/
https://www.ncbi.nlm.nih.gov/pubmed/26229504
http://dx.doi.org/10.2147/CLEP.S85496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514316/
https://www.ncbi.nlm.nih.gov/pubmed/26229504
http://dx.doi.org/10.2147/CLEP.S85496

Ejemplares similares